The burden of inflammatory bowel disease in Europe

被引：856

作者：

Burisch, Johan ^{[1
]}

Jess, Tine ^{[2
]}

Martinato, Matteo ^{[3
]}

Lakatos, Peter L. ^{[4
]}

机构：

[1] Herlev Univ Hosp, Med Sect, Ctr Digest Dis, Copenhagen, Denmark

[2] Natl Ctr Hlth Data & Dis Control, Statens Serum Inst, Dept Epidemiol Res, Copenhagen, Denmark

[3] Univ Padua, Dept Surg Oncol & Gastroenterol Sci, I-35100 Padua, Italy

[4] Semmelweis Univ, Dept Med 1, H-1083 Budapest, Hungary

来源：

JOURNAL OF CROHNS & COLITIS | 2013年 / 7卷 / 04期

关键词：

Inflammatory bowel disease; Incidence; Mortality; Surgery; Disability; Economy; POPULATION-BASED COHORT; CAUSE-SPECIFIC MORTALITY; QUALITY-OF-LIFE; REGIONAL PATIENT GROUP; CROHNS-DISEASE; ULCERATIVE-COLITIS; FOLLOW-UP; COLORECTAL-CANCER; COPENHAGEN COUNTY; INCEPTION COHORT;

D O I：

10.1016/j.crohns.2013.01.010

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

100201 [内科学];

摘要：

Inflammatory bowel diseases (IBD) are chronic disabling gastrointestinal disorders impacting every aspect of the affected individual's life and account for substantial costs to the health care system and society. New epidemiological data suggest that the incidence and prevalence of the diseases are increasing and medical therapy and disease management have changed significantly in the last decade. An estimated 2.5-3 million people in Europe are affected by IBD, with a direct healthcare cost of 4.6-5.6 bn Euros/year. Therefore, the aim of this review is to describe the burden of IBD in Europe by discussing the latest epidemiological data, the disease course and risk for surgery and hospitalization, mortality and cancer risks, as well as the economic aspects, patients disability and work impairment. (c) 2013 European Crohn's and Colitis Organisation. Published by Elsevier B.V. All rights reserved.

引用

页码：322 / 337

页数：16

共 161 条

[1]

History of Medical Hospitalization Predicts Future Need for Colectomy in Patients with Ulcerative Colitis [J].

Ananthakrishnan, Ashwin N. ;

Issa, Mazen ;

Beaulieu, Dawn B. ;

Skaros, Sue ;

Knox, Josh F. ;

Lemke, Kathryn ;

Emmons, Jeanne ;

Lundeen, Sarah H. ;

Otterson, Mary F. ;

Binion, David G. .

INFLAMMATORY BOWEL DISEASES, 2009, 15 (02) :176-181

[2]

Andersen NN, 2012, TUMOR NECROSIS FACTO

[3]

[Anonymous], GUT

[4]

Arin Letamendia Antonio, 2008, Gastroenterol Hepatol, V31, P111, DOI 10.1157/13116497

[5]

Risk of Cancer in Inflammatory Bowel Disease Treated With Azathioprine: A UK Population-Based Case-Control Study [J].

Armstrong, Richard G. ;

West, Joe ;

Card, Timothy R. .

AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 (07) :1604-1609

[6]

Cost of illness of inflammatory bowel disease in the UK: a single centre retrospective study [J].

Bassi, A ;

Dodd, S ;

Williamson, P ;

Bodger, K .

GUT, 2004, 53 (10) :1471-1478

[7]

Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study [J].

Beaugerie, Laurent ;

Brousse, Nicole ;

Bouvier, Anne Marie ;

Colombel, Jean Frederic ;

Lemann, Marc ;

Cosnes, Jacques ;

Hebuterne, Xavier ;

Cortot, Antoine ;

Bouhnik, Yoram ;

Gendre, Jean Pierre ;

Simon, Tabassome ;

Maynadie, Marc ;

Hermine, Olivier ;

Faivre, Jean ;

Carrat, Fabrice .

LANCET, 2009, 374 (9701) :1617-1625

[8]

Risk factors for surgery and postoperative recurrence in Crohn's disease [J].

Bernell, O ;

Lapidus, A ;

Hellers, G .

ANNALS OF SURGERY, 2000, 231 (01) :38-45

[9]

ULCERATIVE-COLITIS AND CROHNS-DISEASE ON THE FAROE ISLANDS 1964-83 - A RETROSPECTIVE EPIDEMIOLOGIC SURVEY [J].

BERNER, J ;

KIAER, T .

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1986, 21 (02) :188-192

[10]

Relationship between sick leave, unemployment, disability, and health-related quality of life in patients with inflammatory bowel disease [J].

Bernklev, T ;

Jahnsen, J ;

Henriksen, M ;

Lygren, I ;

Aadland, E ;

Sauar, J ;

Schulz, T ;

Stray, N ;

Vatn, M ;

Moum, B .

INFLAMMATORY BOWEL DISEASES, 2006, 12 (05) :402-412

← 1 2 3 4 5 6 7 8 9 10 →